Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06526143 · ClinicalTrials.gov registry record · NA
M2VA Pain Care Pathway
A NA study of Pain and Quality of Life, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,800
- Enrollment target
- 1
- Study location
NCT06526143: Recruiting NA study of Pain and Quality of Life, sponsored by Yale University.
NCT06526143 is a NA study of Pain and Quality of Life that is actively recruiting participants, run by Yale University. The registered enrollment target is 1,800 participants, above the 299-participant average among 374 other Pain trials with a reported enrollment target (502% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06526143, a NA study of Pain and Quality of Life, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,800 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this 2-cohort, cluster randomized, type 2 hybrid trial is to test the effectiveness, cost-effectiveness and patient-level effects of an implementation facilitation strategy in helping M2VA case managers adopt a Military2VA Pain Care Pathway (M2VAPCP) intervention. The main questions it aims to answer are: Will adding implementation facilitation to training-as-usual for M2VAPCP result in a higher proportion of Veterans who receive M2VAPCP compared to training-as-usual alone? Will adding implementation facilitation to training-as-usual for M2VAPCP result in better adherence to the M2VAPCP protocol compared to training-as-usual alone? Will implementation facilitation improve Veterans' clinical outcomes (pain, risky substance use) and increase the number of non-pharmacological pain treatments used compared to training-as-usual alone?
Primary Outcome
Proportion of participants who receive any M2VAPCP
Conditions Studied
Interventions
- BEHAVIORAL M2VA Pain Care Pathway (M2VAPCP)
- BEHAVIORAL Implementation Facilitation
Study Locations (1)
Connecticut
- VA Connecticut Healthcare System (VACHS) - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,800 participants |
| Start Date | 2024-09-18 |
| Est. Completion | 2028-07 |
| Phase | NA |
What NCT06526143 shows while recruiting
NCT06526143 is an interventional study that assigns participants to a tested intervention. Its 1,800 participants enrollment target places it among the larger protocols in the corpus, above the 299-participant average among 374 other Pain trials with a reported enrollment target (502% higher).
The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which M2VA Pain Care Pathway (M2VAPCP) is the first listed.
NCT06526143 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06526143 about?
NCT06526143 is a clinical study titled "M2VA Pain Care Pathway". The goal of this 2-cohort, cluster randomized, type 2 hybrid trial is to test the effectiveness, cost-effectiveness and patient-level effects of an implementation facilitation strategy in helping M2VA case managers adopt a Military2VA Pain Care Pathway (M2VAPCP) intervention. The main questions it ...
What is the current status of trial NCT06526143?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,800 participants. The study started on 2024-09-18. Estimated completion is 2028-07.
What conditions does trial NCT06526143 study?
This clinical trial studies the following conditions: Pain, Quality of Life, Substance Use, Opioid Misuse.
What interventions are being tested in trial NCT06526143?
The interventions under investigation include: M2VA Pain Care Pathway (M2VAPCP) (BEHAVIORAL), Implementation Facilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06526143?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06526143 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06526143's enrollment target sits among peer trials
1,800 8th of 374 higher than 367 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
- NCT05258656 · 1,800 participants · NA
Childhood Activities Nutrition and Development Oversight
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI